Results for tag: "Stem Cell Mobilization"

Stem cell mobilization is a process used to increase the number of stem cells in the bloodstream. It is used in the treatment of immune disorders, such as multiple sclerosis, rheumatoid arthritis, and lupus. Stem cell mobilization involves the use of drugs, such as granulocyte-colony stimulating factor (G-CSF) and plerixafor, to stimulate the release of stem cells from the bone marrow into the bloodstream. These drugs are used to increase the number of stem cells available for transplantation, which can help to improve the effectiveness of the treatment. The stem cell mobilization market is expected to grow in the coming years, driven by the increasing prevalence of immune disorders and the growing demand for stem cell therapies. Additionally, the development of new drugs and technologies for stem cell mobilization is expected to further drive the market growth. Some of the key players in the stem cell mobilization market include Amgen, Inc., Pfizer, Inc., Novartis AG, Merck & Co., Inc., and Johnson & Johnson. Show Less Read more